Skip to main content
SpringerLink
Log in

Evidence Based Management in Recurrent Pregnancy Loss

  • Chapter
  • First Online:
Recurrent Pregnancy Loss

  • 807 Accesses

Abstract

Recurrent pregnancy loss (RPL) is defined as three pregnancy losses before the 20th week of gestation and excludes ectopic, molar, and biochemical pregnancies. The American Society of Reproductive Medicine (ASRM) recommends clinical evaluation following two first-trimester pregnancy losses [1]. RPL has been associated with factors related to genetics; age; anatomic, immunological, congenital, and acquired thrombophilias; errors of metabolism; hormonal imbalance; infections; sperm parameters; and lifestyle issues. But still despite a thorough evaluation, 50% of cases of RPL will remain unexplained (Fig. 15.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Practice Committee Opinion of the American Society of Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103–11.

    Article  Google Scholar 

  2. Regan L, Backos M, Rai R. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG Green-top Guideline No. 17. April 2010. http://www.rcog.org.uk/files/rcog-corp/GTG17recurrentmiscarriage.pdf.

  3. Fischer J, Colls P, Escudero T, et al. Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses. Fertil Steril. 2010;94:283–9.

    Article  Google Scholar 

  4. Lim CK, Jun JH, Min DM, et al. Efficacy and clinical outcome of preimplantation genetic diagnosis using FISH for couples of reciprocal and Robertsonian translocations: the Korean experience. Prenat Diagn. 2004;24:556–61.

    Article  Google Scholar 

  5. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005;83:821–39.

    Article  Google Scholar 

  6. Scriven PN, Flinter FA, Khalaf Y, et al. Benefits and drawbacks of preimplantation genetic diagnosis (PGD) for reciprocal translocations: lessons from a prospective cohort study. Eur J Hum Genet. 2013;21:1035–41.

    Article  Google Scholar 

  7. Mastenbroek S, Twisk M, van Echten-Arends J, et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357:9–17.

    Article  CAS  Google Scholar 

  8. Practice Committee of Society for Assisted Reproductive Technology, Practice Committee of American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril. 2008;90:S136–43.

    Google Scholar 

  9. Forman EJ, Tao X, Ferry KM, et al. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod. 2012;27:1217–22.

    Article  CAS  Google Scholar 

  10. Acien P, Acien M, Sanchez-Ferrer M. Complex malformations of the female genital tract. New types and revision of classification. Hum Reprod. 2004;19:2377–84.

    Article  Google Scholar 

  11. Grimbizis GF, Camus M, Tarlatzis BC, et al. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update. 2001;7:161–74.

    Article  CAS  Google Scholar 

  12. Sugiura-Ogasawara M, Ozaki Y, Katano K, Suzumori N, Mizutani E. Uterine anomaly and recurrent pregnancy loss. Semin Reprod Med. 2011;29:514–21.

    Article  Google Scholar 

  13. Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin North Am. 2015;42:117–34.

    Article  Google Scholar 

  14. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol. 2005;106:181–9.

    Article  Google Scholar 

  15. Owen J, Hankins G, Iams JD, Berghella V, Sheffield JS, Perez-Delboy A, et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol. 2009;201:375.e1–8.

    Article  Google Scholar 

  16. American College of Obstetrics and Gynecologist. ACOG practice bulletin No 142. Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014;123(2 Pt 1):372–9.

    Google Scholar 

  17. Royal College of Obstetricians & Gynecologists. Green Top Guidelines No 60. Cervical cerclage. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg60.

  18. Brix N, Secher NJ, McCormack CD, Helmig RB, Hein M, Weber T, et al. Randomised trial of cervical cerclage, with and without occlusion, for the prevention of preterm birth in women suspected for cervical insufficiency. BJOG. 2013;120:613–20.

    Article  CAS  Google Scholar 

  19. Namouz S, Porat S, Okun N, Windrim R, Farine D. Emergency cerclage: literature review. Obstet Gynecol Surv. 2013;68:379–88.

    Article  Google Scholar 

  20. Hume H, Rebarber A, Saltzman DH, Roman AS, Fox NS. Ultrasound-indicated cerclage: Shirodkar vs. McDonald. J Matern Fetal Neonatal Med. 2012;25:2690–2.

    Article  Google Scholar 

  21. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O’Brien JM, Cetingoz E, et al. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol. 2013;208:42.e1–8.

    Article  CAS  Google Scholar 

  22. Melamed N, Hiersch L, Domniz N, Maresky A, Bardin R, Yogev Y. Predictive value of cervical length in women with threatened preterm labor. Obstet Gynecol. 2013;122:1279–87.

    Article  Google Scholar 

  23. Groot LD, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543–65.

    Article  Google Scholar 

  24. Greene MF, Hare JW, Cloherty JP, et al. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39:225–31.

    Article  CAS  Google Scholar 

  25. Yan J, Sripada S, Saravelos SH, Chen ZJ, Egner W, Li TC. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy. Fertil Steril. 2012;98:378–82.

    Article  CAS  Google Scholar 

  26. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril. 1998;70:246–52.

    Article  CAS  Google Scholar 

  27. Murray MJ, Meyer WR, Zaino RJ, et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril. 2004;81:1333–43.

    Article  Google Scholar 

  28. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2013;(10):CD003511.

    Google Scholar 

  29. Kumar A, Begum N, Prasad S, Aggarwal S, Sharma S. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril. 2014;102(5):1357.e3–63.e3.

    Article  Google Scholar 

  30. Coomarasamy A, Williams H, Truchanowicz E, Seed PT, et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015;373:2141–8.

    Article  CAS  Google Scholar 

  31. Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage: a reappraisal. Hum Reprod. 2000;15:612–5. [PubMed: 10686206].

    Article  CAS  Google Scholar 

  32. Li ZL, Xiang HF, Cheng LH, Cao YX, Wei ZL, Liu C, et al. Association between recurrent miscarriages and insulin resistance: a meta analysis. Zhonghua Fu Chan Ke Za Zhi. 2012;47:915–9.

    PubMed  Google Scholar 

  33. Carrington B, Sacks G, Regan L. Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol. 2005;17:591–7.

    Article  Google Scholar 

  34. de Jong PG, Kaandorp S, Di Nisio M, et al. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev. 2014;(7):CD004734.

    Google Scholar 

  35. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol. 1989;160:439–43.

    Article  CAS  Google Scholar 

  36. Ziakis PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss. A systematic review and meta-analysis. Obstet Gynecol. 2010;115:1256–62.

    Article  Google Scholar 

  37. Hutton B, Sharma R, Fergusson D, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG. 2007;114:134–42.

    Article  CAS  Google Scholar 

  38. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006;(2):CD000112.

    Google Scholar 

  39. Creus M, Deulofeu R, Peñarrubia J, Carmona F, Balasch J. Plasma homocysteine and vitamin B12 serum levels, red blood cell folate concentrations, C677T methylenetetrahydrofolate reductase gene mutation and risk of recurrent miscarriage: a case-control study in Spain. Clin Chem Lab Med. 2013;51:693–9.

    Article  CAS  Google Scholar 

  40. Zini A. Are sperm chromatin and DNA defects relevant in the clinic? Syst Biol Reprod Med. 2011;57:78–85.

    Article  Google Scholar 

  41. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21:375–90.

    Article  Google Scholar 

  42. Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev. 2009;(1):CD004734.

    Google Scholar 

  43. Niekerk EC, Siebert I, Kruger TF. An evidence based approach to recurrent pregnancy loss. S Afr J Obstet Gynaecol. 2013;19(3):61–5.

    Google Scholar 

  44. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol. 1984;148:140–6.

    Article  CAS  Google Scholar 

  45. Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyák K, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;362:1586–96.

    Article  CAS  Google Scholar 

  46. Morley LC, Simpson N, Tang T. Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database Syst Rev. 2013;(1):CD008611.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obstetrics and Gynecology, University College of Medical Sciences and GTB Hospital, Delhi, India

    Rashmi

Authors
  1. Rashmi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rashmi .

Editor information

Editors and Affiliations

  1. Department of Obstetrics & Gynecology, Babu Jagjivan Ram Memorial Hospital, New Delhi, India

    Sumita Mehta

  2. Department of Obstetrics and Gynecology, UCMS & GTB Hospital, New Delhi, India

    Bindiya Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rashmi (2018). Evidence Based Management in Recurrent Pregnancy Loss. In: Mehta, S., Gupta, B. (eds) Recurrent Pregnancy Loss. Springer, Singapore. https://doi.org/10.1007/978-981-10-7338-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7338-0_15

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7337-3

  • Online ISBN: 978-981-10-7338-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation